Clinical Trial Assessing the Efficacy and Safety of Hépar® in Chronic Constipation

NACompletedINTERVENTIONAL

Enrollment

262

Participants

Timeline

Start Date

January 30, 2015

Primary Completion Date

July 22, 2016

Study Completion Date

July 22, 2016

Conditions

Constipation - Functional

Interventions

OTHER

Taking two kinds of mineral water

1.5L of low-mineral water (Vittel Bonne Source, control group) or 1L of Hépar + 0.5L of low-mineral water (Hépar group).

Trial Locations (1)

Quanta Medical, Rueil-Malmaison

All Listed Sponsors

lead

Quanta Medical

INDUSTRY

NCT03348007 - Clinical Trial Assessing the Efficacy and Safety of Hépar® in Chronic Constipation | Biotech Hunter | Biotech Hunter